Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis

Clinical trial NCT05105958 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05105958
Sponsor: University of Zurich
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2025-12-01
Primary completion: 2025-12-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.